MS vs CME
By Alex · Tickerpine
Morgan Stanley vs CME Group Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | CME |
|---|---|---|
| Price | $212.03 | $221.00 |
| Market cap | $334.43B | $79.85B |
| P/E ratio | 19.2 | 18.9 |
| ROE | 16.39% | 15.92% |
| Profit margin | 24.75% | 63.32% |
| Revenue growth | 16.30% | 14.40% |
| Dividend yield | 1.89% | 2.35% |
| Beta | 1.22 | 0.24 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs CME in plain English
- MS is the bigger company — about 4.2× the market cap of CME.
- CME is cheaper on earnings (P/E 18.9 vs 19.2).
- MS earns a higher return on equity (16% vs 16%).
- MS is growing revenue faster (16% vs 14%).
- CME has the higher dividend yield (2.35% vs 1.89%).
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
CME return calculator
See what $1,000 in CME Group Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.